Did you know?
Multiple sclerosis is the most common degenerative neurological condition diagnosed in young adults, with over 75% of people diagnosed under the age of 40.
New MS treatment available on Pharmaceutical Benefits Scheme
Lemtrada® (alemtuzumab), a new therapy for people living with relapsing-remitting multiple sclerosis (MS), will be available on the Pharmaceutical Benefits Scheme (PBS) from 1 April 2015.Read more
Stomach Ulcer bug may protect against MS
A West Australian team has found evidence that the stomach ulcer bacterium, Helicobacter pylori, is associated with a lower risk of multiple sclerosis (MS), bolstering evidence for the role of the ‘hygiene hypothesis’ in autoimmune disorders.Read more
Young Carer Finalist
Living with multiple sclerosis (MS) can be a challenge, but when you have the support of your family and friends, it makes the difference between wanting to fight, and the thought of giving up. For Branka Smiljanic, the support of her 11-year-old-son, Alexander Tanasijevic, is Branka’s reason to fight.Read more
Members take out Canning Show prize
On 31 October, five very talented MSWA Members were brave enough to put their handiwork up for scrutiny in the 2014 Canning Show. Mosaic tiles, paintings and flower arrangements were among some of the submissions and if they were nervous about how they would fare, the results proved that they didn’t need to be.Read more
How Client services costs are allocated?
Without your contribution, and government funding, we couldn’t continue to provide services to thousands of Western Australians with MS.